Drug price review is the process a health insurer or health plan uses to evaluate prescription pricing and decide what it will reimburse under the pharmacy benefit. In plain language, it is the pricing review that helps determine how much the plan will pay for a drug claim and how much cost will be pushed back to the member.
What the review considers
Drug price review can involve:
- benchmark pricing data
- negotiated network pharmacy rates
- generic versus brand alternatives
- specialty-drug cost controls
- tier placement and utilization rules
The review is not just about finding the lowest sticker price. Insurers also consider how pricing interacts with formulary design, clinical use, and expected claims volume.
Why it matters in insurance operations
Pharmacy benefits can produce large aggregate claim costs, so pricing review affects:
- member cost sharing
- plan reimbursement schedules
- formulary strategy
- premium adequacy and benefit design
When drug costs change quickly, the insurer or plan sponsor has to decide whether to absorb the increase, change coverage rules, or redesign the benefit at renewal.
Practical example
A plan reviews a high-cost specialty medication before the next contract year. After analyzing benchmark pricing and claim frequency, the plan moves the drug to a specialty tier, adjusts reimbursement expectations, and adds prior authorization rules to control claim costs while keeping coverage available under specific conditions.
Related Terms
- Drug Formulary
- Drug Utilization Review
- Pharmacy and Therapeutics Committee
- Major Medical Insurance
- Health Insurance